Talis Biomedical Corporat... (TLIS)
1.55
-0.01 (-0.64%)
At close: Jan 14, 2025, 8:00 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -0.22 | -0.11 | -0.48 | -1.33 | -2.28 | -2.94 |
| PS Ratio | 32.87 | 3.25 | n/a | 11.06 | 15.73 | 26.24 |
| PB Ratio | 0.20 | 0.09 | 0.39 | -1.11 | -2.96 | -1.21 |
| P/FCF Ratio | -0.25 | -0.12 | -0.52 | -1.27 | -2.51 | -2.92 |
| P/OCF Ratio | -0.25 | -0.12 | -0.53 | -1.39 | -2.57 | -3 |
| OCF/S Ratio | -129.22 | -27.42 | n/a | -7.96 | -6.12 | -8.76 |
| Debt / Equity Ratio | 0.28 | 0.26 | 0.06 | -0.01 | n/a | n/a |
| Quick Ratio | 8.86 | 10.52 | 12.36 | 8.86 | 5.97 | 2.77 |
| Current Ratio | 8.86 | 10.52 | 12.36 | 11.78 | 5.97 | 2.77 |
| Asset Turnover | 0.00 | 0.02 | n/a | 0.06 | 0.15 | 0.21 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.9 | -0.87 | -0.81 | 0.84 | 1.30 | 0.41 |
| Return on Assets (ROA) | -0.65 | -0.66 | -0.72 | -0.46 | -1.07 | -1.88 |
| Return on Capital (ROIC) | -0.78 | -0.74 | -0.78 | -0.5 | -1.23 | -2.68 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 90.05% | -129.76% | n/a | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | -15.05K% | -3.04K% | n/a | -832.66% | -689.77% | -892.76% |
| Pretax Profit Margin | -15.05K% | -3.09K% | n/a | -833.15% | -690.82% | -892.76% |
| Operating Profit Margin | -16.22K% | -3.15K% | n/a | -833.64% | -671.34% | -896.65% |
| FCF Margin | -13.04K% | -2.79K% | n/a | -870.59% | -626.2% | -898.58% |
| EBITDA Margin | -16.03K% | -2.91K% | n/a | -826.67% | -653.08% | -869.58% |